Illinois General Assembly

  Bills & Resolutions  
  Compiled Statutes  
  Public Acts  
  Legislative Reports  
  IL Constitution  
  Legislative Guide  
  Legislative Glossary  

 Search By Number
 (example: HB0001)
Search Tips

Search By Keyword

Illinois Compiled Statutes

 ILCS Listing   Public Acts  Search   Guide   Disclaimer

Information maintained by the Legislative Reference Bureau
Updating the database of the Illinois Compiled Statutes (ILCS) is an ongoing process. Recent laws may not yet be included in the ILCS database, but they are found on this site as Public Acts soon after they become law. For information concerning the relationship between statutes and Public Acts, refer to the Guide.

Because the statute database is maintained primarily for legislative drafting purposes, statutory changes are sometimes included in the statute database before they take effect. If the source note at the end of a Section of the statutes includes a Public Act that has not yet taken effect, the version of the law that is currently in effect may have already been removed from the database and you should refer to that Public Act to see the changes made to the current law.

410 ILCS 705/5-25

    (410 ILCS 705/5-25)
    (Text of Section before amendment by P.A. 102-1006)
    Sec. 5-25. Department of Public Health to make health warning recommendations.
    (a) The Department of Public Health shall make recommendations to the Department of Agriculture and the Department of Financial and Professional Regulation on appropriate health warnings for dispensaries and advertising, which may apply to all cannabis products, including item-type specific labeling or warning requirements, regulate the facility where cannabis-infused products are made, regulate cannabis-infused products as provided in subsection (e) of Section 55-5, and facilitate the Adult Use Cannabis Health Advisory Committee.
    (b) An Adult Use Cannabis Health Advisory Committee is hereby created and shall meet at least twice annually. The Chairperson may schedule meetings more frequently upon his or her initiative or upon the request of a Committee member. Meetings may be held in person or by teleconference. The Committee shall discuss and monitor changes in drug use data in Illinois and the emerging science and medical information relevant to the health effects associated with cannabis use and may provide recommendations to the Department of Human Services about public health awareness campaigns and messages. The Committee shall include the following members appointed by the Governor and shall represent the geographic, ethnic, and racial diversity of the State:
        (1) The Director of Public Health, or his or her
    
designee, who shall serve as the Chairperson.
        (2) The Secretary of Human Services, or his or her
    
designee, who shall serve as the Co-Chairperson.
        (3) A representative of the poison control center.
        (4) A pharmacologist.
        (5) A pulmonologist.
        (6) An emergency room physician.
        (7) An emergency medical technician, paramedic, or
    
other first responder.
        (8) A nurse practicing in a school-based setting.
        (9) A psychologist.
        (10) A neonatologist.
        (11) An obstetrician-gynecologist.
        (12) A drug epidemiologist.
        (13) A medical toxicologist.
        (14) An addiction psychiatrist.
        (15) A pediatrician.
        (16) A representative of a statewide professional
    
public health organization.
        (17) A representative of a statewide hospital/health
    
system association.
        (18) An individual registered as a patient in the
    
Compassionate Use of Medical Cannabis Program.
        (19) An individual registered as a caregiver in the
    
Compassionate Use of Medical Cannabis Program.
        (20) A representative of an organization focusing on
    
cannabis-related policy.
        (21) A representative of an organization focusing on
    
the civil liberties of individuals who reside in Illinois.
        (22) A representative of the criminal defense or
    
civil aid community of attorneys serving Disproportionately Impacted Areas.
        (23) A representative of licensed cannabis business
    
establishments.
        (24) A Social Equity Applicant.
        (25) A representative of a statewide community-based
    
substance use disorder treatment provider association.
        (26) A representative of a statewide community-based
    
mental health treatment provider association.
        (27) A representative of a community-based substance
    
use disorder treatment provider.
        (28) A representative of a community-based mental
    
health treatment provider.
        (29) A substance use disorder treatment patient
    
representative.
        (30) A mental health treatment patient representative.
    (c) The Committee shall provide a report by September 30, 2021, and every year thereafter, to the General Assembly. The Department of Public Health shall make the report available on its website.
(Source: P.A. 101-27, eff. 6-25-19; 101-593, eff. 12-4-19.)
 
    (Text of Section after amendment by P.A. 102-1006)
    Sec. 5-25. Department of Public Health to make health warning recommendations.
    (a) The Department of Public Health shall make recommendations to the Department of Agriculture and the Department of Financial and Professional Regulation on appropriate health warnings for dispensaries and advertising, which may apply to all cannabis products, including item-type specific labeling or warning requirements, regulate the facility where cannabis-infused products are made, regulate cannabis-infused products as provided in subsection (e) of Section 55-5, and facilitate the Adult Use Cannabis Health Advisory Committee.
    (b) An Adult Use Cannabis Health Advisory Committee is hereby created and shall meet at least twice annually. The Chairperson may schedule meetings more frequently upon his or her initiative or upon the request of a Committee member. Meetings may be held in person or by teleconference. The Committee shall discuss and monitor changes in drug use data in Illinois and the emerging science and medical information relevant to the health effects associated with cannabis use and may provide recommendations to the Department of Human Services about public health awareness campaigns and messages. The Committee shall include the following members appointed by the Governor and shall represent the geographic, ethnic, and racial diversity of the State:
        (1) The Director of Public Health, or his or her
    
designee, who shall serve as the Chairperson.
        (2) The Secretary of Human Services, or his or her
    
designee, who shall serve as the Co-Chairperson.
        (3) A representative of the poison control center.
        (4) A pharmacologist.
        (5) A pulmonologist.
        (6) An emergency room physician.
        (7) An emergency medical technician, paramedic,
    
emergency medical dispatcher, or other first responder.
        (8) A nurse practicing in a school-based setting.
        (9) A psychologist.
        (10) A neonatologist.
        (11) An obstetrician-gynecologist.
        (12) A drug epidemiologist.
        (13) A medical toxicologist.
        (14) An addiction psychiatrist.
        (15) A pediatrician.
        (16) A representative of a statewide professional
    
public health organization.
        (17) A representative of a statewide hospital/health
    
system association.
        (18) An individual registered as a patient in the
    
Compassionate Use of Medical Cannabis Program.
        (19) An individual registered as a caregiver in the
    
Compassionate Use of Medical Cannabis Program.
        (20) A representative of an organization focusing on
    
cannabis-related policy.
        (21) A representative of an organization focusing on
    
the civil liberties of individuals who reside in Illinois.
        (22) A representative of the criminal defense or
    
civil aid community of attorneys serving Disproportionately Impacted Areas.
        (23) A representative of licensed cannabis business
    
establishments.
        (24) A Social Equity Applicant.
        (25) A representative of a statewide community-based
    
substance use disorder treatment provider association.
        (26) A representative of a statewide community-based
    
mental health treatment provider association.
        (27) A representative of a community-based substance
    
use disorder treatment provider.
        (28) A representative of a community-based mental
    
health treatment provider.
        (29) A substance use disorder treatment patient
    
representative.
        (30) A mental health treatment patient representative.
    (c) The Committee shall provide a report by September 30, 2021, and every year thereafter, to the General Assembly. The Department of Public Health shall make the report available on its website.
(Source: P.A. 101-27, eff. 6-25-19; 101-593, eff. 12-4-19; 102-1006, eff. 1-1-23.)